サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK

CountryFocus:イギリスにおける医療、規制、および医療費償還制度の展望

レポート概要

本レポートは、イギリスにおける医療、規制、および医療費償還制度の展望に関する情報や分析に不可欠な情報を提供し、医療市場における主要動向を明らかにします。また、人口動態、規制、医療費償還制度の展望、および医療インフラに関する見識を提供します。さらに、製薬および医療機器市場の動向やセグメントに関する貴重な情報を提供します。 本レポートは、業界の専門家からなる自社チームによる独自のデータベース、一次調査と二次調査、および自社分析を基にしたデータや情報を盛り込んでいます。

イギリスの医薬品市場価値は、2010年の132億ポンドから2017年には196億ポンドに増加し、複合年間成長率(CAGR)はイギリスポンド(GBP)で5.9%、米ドル(USD)で3.5%でした。2022年には、市場規模は262億ポンド(309億ドル)に達すると予測されています。医薬品市場の主な促進要因は、デジタル技術を薬物開発に取り入れ、薬剤アクセス経路を加速させたこと、高齢者における疾病負担の高まりと高齢者人口の増加です。 2015年のイギリスの医療機器市場は178億ドルに達し、2017年のCAGRは3.6%で、191億ドルに拡大しました。また2018年の198億ドルから2025年には263億ドルまで4.1%のCAGRで成長すると予想されます。主なセグメントは体外診断、眼科用機器、心臓血管用機器、創傷治療用機器および整形外科用機器でした。個別化または精密医薬品の開発、遺伝子配列決定および個人ゲノムデータの組み込みは、医療従事者および製薬産業が疾患治療のために取り組んでいるアプローチに革命をもたらしています。

■調査範囲

  • 市場規模、市場セグメント、主要推進要因、および障壁など、イギリスにおける製薬および医療機器市場の概説
  • 主要企業のプロファイルとSWOT分析
    ➣ 主要製薬企業:AstraZeneca、GlaxoSmithKline、Merck、Novartis、Pfizer
    ➣ 主要医療機器企業:Siemens、Roche、DePuy、Essilor、Smith & Nephew
  • イギリスの医薬品および医療機器市場における最近完了した取引に関する詳細な分析
  • イギリスの医薬品・医療機器市場におけるPorter’s five forces分析
  • ヘルスケア償還プロセス、規制機関、新薬および医療機器の承認プロセスの詳細を含む、償還および規制状況の洞察を深めたレビュー
  • 最近の医療政策、医療インフラおよび医療費に関する情報
  • イギリスの医療市場における成長の機会と成長の課題の概要

レポート詳細

目次

Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List of Tables
Table 1: Pharmaceutical Market, UK, Sales of Patented Drug Products by Major Therapeutic Class ($bn), 2016
Table 2: Medical Device Market, UK, Revenue by Segment ($bn), 2017
Table 3: InVitro Diagnostics Devices Market, UK, Revenue and Market Share of Major Players
Table 4: Ophthalmic Devices Market, UK, Revenue and Market Share of Major Players
Table 5: Cardiovascular Devices Market, UK, Revenue and Market Share of Major Players
Table 6: Wound Care Devices Market, UK, Revenue and Market Share of Major Players
Table 7: Orthopedic Devices Market, UK, Revenue and Market Share of Major Players
Table 8: Market Access, Forecasts and Profile Of Annual Payment Percentages, UK, 2014-2018
Table 9: Patent Fees ($), 2018, UK
Table 10: Trademark Fees ($), 2018, UK
Table 11: Clinical Trials Application Fees ($), 2018, UK
Table 12: Clinical Trials Application Fees ($) for Medical Devices, 2018, UK
Table 13: Trade Associations, UK
Table 14: Trade Fairs, UK

List of Figures
Figure 1: Pharmaceutical Market, UK, Revenue, 2015-2022
Figure 2: Medical Device Market, UK, Revenue, 2015-2020
Figure 3: UK Brexit Timeline, UK, 2018
Figure 4: Number of Deals (2017-2018)
Figure 5: 2017-2018 Deal Overview By Region
Figure 6: Country Profile, UK, 2018
Figure 7: Pharmaceutical Market, UK, Revenue, 2010-2017
Figure 8: Pharmaceutical Market, UK, Revenue Forecast, 2018-2022
Figure 9: Pharmaceutical Market, UK, Pharmaceutical Exports
Figure 10: Pharmaceutical Market, UK, Top Export Partners
Figure 11: Pharmaceutical Market, UK, Pharmaceutical Imports
Figure 12: Pharmaceutical Market, UK, Top Import Partners
Figure 13: Pharmaceutical Market, UK, Supply Channels
Figure 14: Pharmaceutical Market, UK, Sales of OTC drugs by Major Therapeutic Segments, 2018
Figure 15: Pharmaceutical Market, UK, Sales of Patented Drug Products by Major Therapeutic Class, 2016
Figure 16: Pharmaceutical Market, UK, Sales of Patented Drug Products by Major Therapeutic Class ($bn), 2016
Figure 17: Pharmaceutical Market, UK, Major Players
Figure 18: Medical Device Market, UK, Revenue, 2015-2020
Figure 19: Medical Device Market, UK, Revenue Forecast, 2021-2025
Figure 20: Medical Device Market, UK, Revenue by Segment, 2017
Figure 21: InVitro Diagnostics Devices Market, UK, Revenue
Figure 22: InVitro Diagnostics Devices Market, UK, Market Share of Major Players
Figure 23: Ophthalmic Devices Market, UK, Revenue
Figure 24: Ophthalmic Devices Market, UK, Market Share of Major Players
Figure 25: Cardiovascular Devices Market, UK, Revenue
Figure 26: Cardiovascular Devices Market, UK, Market Share of Major Players
Figure 27: Wound Care Devices Market, UK, Revenue
Figure 28: Wound Care Devices Market, UK, Market Share of Major Players
Figure 29: Orthopedic Devices Market, UK, Revenue
Figure 30: Orthopedic Devices Market, UK, Market Share of Major Players
Figure 31: Diagnostic Market, UK, Revenue ($bn), 2015-2020
Figure 32: Diagnostic Market, UK, Revenue Forecast ($bn), 2021-2025
Figure 33: Medical Device Market, UK, Revenue of Major Players, 2016
Figure 34: Deal Value and Deal Count, Pharmaceutical Market, UK, 2017-2018
Figure 35: Deal Value and Deal Count Quarterly, Pharmaceutical Market, UK, 2017-2018
Figure 36: Deal Value and Deal Count Sub-types, Pharmaceutical Market, UK, 2017-2018
Figure 37: Top Five Therapy Area by Deal Value, Pharmaceutical Market, UK, 2017-2018
Figure 38: Top Five Therapy Area by Deal Number, Pharmaceutical Market, UK, 2017-2018
Figure 39: M&A Deals by Therapy Area, Pharmaceutical Market, UK, 2017-2018
Figure 40: Venture Financing Deals by Therapy Area, Pharmaceutical Market, UK, 2017-2018
Figure 41: Private Equity Deals by Therapy Area, Pharmaceutical Market, UK, 2017-2018
Figure 42: Medical Device Market Deals, UK, 2017-2018 (by Deal Value, $m)
Figure 43: Medical Device Market Deals, UK, 2017- 2018 (by Deal Count)
Figure 44: Medical Device Market Deals Share (by Deal Count), UK, 2017-2018
Figure 45: Medical Device Market Deals Share (by Deal Value), UK, 2017-2018
Figure 46: Medical Device, Top Therapy Area by Deal Value, UK, 2017-2018
Figure 47: Medical Device, Top Therapy Area by Deal Number, UK, 2017-2018
Figure 48: M&A Deals by Therapy Area, Medical Device, UK, 2017-2018 (by Value and by Number)
Figure 49: Venture Financing Deals by Therapy Area, Medical Device, UK, 2017-2018 (by Value and by Number)
Figure 50: Private Equity Deals by Therapy Area, Medical Device, UK, 2017-2018 (by Value and by Number)
Figure 51: Healthcare Market, UK, Overview of Health System, 2018
Figure 52: Overview of Finance Flow, UK, 2018
Figure 53: NHS Departmental Expenditure Limit ($bn), UK, 2015-2021
Figure 54: Market Access, Reimbursement Schemes, UK, 2016
Figure 55: OOP Expenditure (% of Total Expenditure on Health), UK, 2010-2017
Figure 56: Annual Average Rates of Price Change (%), Medicines Price Index, UK, 2010-2017
Figure 57: Market Access, MHRA Structure, UK, 2018
Figure 58: Centralized Procedure, UK, 2018
Figure 59: Centralized Procedure, EU, 2018
Figure 60: Decentralized Procedure, EU, 2018
Figure 61: Mutual Recognition Procedure, UK, 2018
Figure 62: Life Cycle of Medical Device, UK, 2018
Figure 63: Conformity Assessment of Class I Medical Devices, EU, 2018
Figure 64: Conformity Assessment of Class IIa Medical Devices, EU, 2018
Figure 65: Conformity Assessment of Class IIb Medical Devices, EU, 2018
Figure 66: Conformity Assessment of Class III Medical Devices, EU, 2018
Figure 67: Licensing Procedure for Pharmaceutical Manufacturing, UK, 2018
Figure 68: Patent Approval Process, UK, 2018
Figure 69: European Patent Approval Process, EU, 2017
Figure 70: Unitary Patent Approval Process, EU, 2017
Figure 71: Trademark Approval Process, UK, 2018
Figure 72: Clinical Trial Authorization (CTA) Application Flowchart, 2017, UK
Figure 73: Market Access, UK, Clinical Trial Regulation Process for Medical Devices, 2018
Figure 74: Market Access, Regulatory Changes in the UK Before and After Brexit, 2018
Figure 75: Number of Hospitals, UK, 2010-2017
Figure 76: Diagnostic Equipment (per Million Population), UK, 2010-2017
Figure 77: Hospital Beds (per 1,000 Population), UK
Figure 78: Psychiatric Hospital Beds (per 1,000 Population), UK
Figure 79: Life Expectancy, 2010-2017, UK
Figure 80: Immunization Rate (%), 2010-2017, UK
Figure 81: PM2.5 (μg per m3), UK, 2010-2017
Figure 82: CO2 Emissions (Million Tons), UK, 2010-2017
Figure 83: Physicians (per 1,000 Population), UK, 2010-2016
Figure 84: Nurses (per 1,000 Population), UK, 2010-2016
Figure 85: Dentists (per 1,000 Population), UK, 2010-2016
Figure 86: Pharmacists (per 1,000 Population), UK, 2010-2016
Figure 87: Major Causes of Mortality (per 1,000 Population), UK, 2016
Figure 88: Major Causes of Male Mortality, UK, 2016
Figure 89: Major Causes of Female Mortality, UK, 2016
Figure 90: Disability-Adjusted Life Years by Major Disease (‘000), UK, 2016
Figure 91: Healthcare Expenditure as Percentage of GDP (%), UK, 2010-2017
Figure 92: Public-Private Share (%), UK, 2010-2017
Figure 93: Major Components of Healthcare Spending (%), UK, 2016
Figure 94: Opportunities and Challenges, UK

発刊日

2018/12/01

体裁

PDF / 169ページ

販売価格

1,995USD

発行

GlobalData

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医薬品産業(医療制度、医療観光など)

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE